The impact of incident depression on medication adherence in patients with type 2 diabetes.

[1]  J. Moisan,et al.  Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada , 2016, Medicine.

[2]  Z. Bloomgarden,et al.  Determinants of adherence to diabetes treatment , 2015, Journal of diabetes.

[3]  M. Dorais,et al.  Persistence and adherence to oral antidiabetics: a population-based cohort study , 2015, Acta Diabetologica.

[4]  Subashan Perera,et al.  Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. , 2013, Research in social & administrative pharmacy : RSAP.

[5]  J. Moisan,et al.  Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance. , 2013, Diabetes & metabolism.

[6]  V. Woo,et al.  Pharmacologic management of type 2 diabetes. , 2013, Canadian journal of diabetes.

[7]  E. Mannucci,et al.  Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. , 2013, Diabetes research and clinical practice.

[8]  M. Bounthavong,et al.  Revisiting the medication possession ratio threshold for adherence in lipid management , 2013, Current medical research and opinion.

[9]  R. Alaghehbandan,et al.  Using administrative databases in the surveillance of depressive disorders--case definitions. , 2012, Population health management.

[10]  H. Brenner,et al.  Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. , 2012, Diabetes research and clinical practice.

[11]  Nick Barber,et al.  Suitability of measures of self-reported medication adherence for routine clinical use: A systematic review , 2011, BMC medical research methodology.

[12]  Elena Losina,et al.  Evaluation of exposure-specific risks from two independent samples: A simulation study , 2011, BMC medical research methodology.

[13]  R. Hansen,et al.  A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. , 2010, Clinical therapeutics.

[14]  H. Wittchen,et al.  Diabetes in Primary Care: Prospective Associations between Depression, Nonadherence and Glycemic Control , 2010, Psychotherapy and Psychosomatics.

[15]  W. Katon,et al.  Diabetes and Poor Disease Control: Is Comorbid Depression Associated With Poor Medication Adherence or Lack of Treatment Intensification? , 2009, Psychosomatic medicine.

[16]  Bradley C Martin,et al.  Good and poor adherence: optimal cut-point for adherence measures using administrative claims data , 2009, Current medical research and opinion.

[17]  M. Mimiaga,et al.  Depression and Diabetes Treatment Nonadherence: A Meta-Analysis , 2008, Diabetes Care.

[18]  J. Meigs,et al.  Symptoms of depression prospectively predict poorer self‐care in patients with Type 2 diabetes , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[19]  C. Fox,et al.  Assessing the Prevalence of Depression among Individuals with Diabetes in a Medicaid Managed-Care Program , 2008, International journal of psychiatry in medicine.

[20]  Samy Suissa,et al.  Immortal time bias in pharmaco-epidemiology. , 2008, American journal of epidemiology.

[21]  L. Egede.  Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. , 2007, General hospital psychiatry.

[22]  C. Lance,et al.  Predicting adherence to immunosuppressant therapy: a prospective analysis of the theory of planned behaviour. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  C. Croux,et al.  Depression and socio-economic risk factors: 7-year longitudinal population study , 2007, British Journal of Psychiatry.

[24]  D. Mohr,et al.  Clinical Depression Versus Distress Among Patients With Type 2 Diabetes , 2007, Diabetes Care.

[25]  James A Hanley,et al.  Do Oscar Winners Live Longer than Less Successful Peers? A Reanalysis of the Evidence , 2006, Annals of Internal Medicine.

[26]  M. Amonkar,et al.  Depression in Patients with Type 2 Diabetes: Impact on Adherence to Oral Hypoglycemic Agents , 2006, The Annals of pharmacotherapy.

[27]  J. Aikens,et al.  The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. , 2005, Research in social & administrative pharmacy : RSAP.

[28]  Michal Abrahamowicz,et al.  Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. , 2005, American journal of epidemiology.

[29]  J. Moisan,et al.  Measures of adherence based on self-report exhibited poor agreement with those based on pharmacy records. , 2005, Journal of clinical epidemiology.

[30]  A. Kilbourne,et al.  How does depression influence diabetes medication adherence in older patients? , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[31]  E. Ha,et al.  Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. , 2004, Journal of clinical epidemiology.

[32]  K. Humphreys,et al.  Depression Increases Diabetes Symptoms by Complicating Patients’ Self-Care Adherence , 2004, The Diabetes educator.

[33]  Robert J Glynn,et al.  How well do patients report noncompliance with antihypertensive medications?: a comparison of self‐report versus filled prescriptions , 2004, Pharmacoepidemiology and drug safety.

[34]  J. Wogen,et al.  Utilization of oral hypoglycemic agents in a drug-insured U.S. population. , 2001, Diabetes care.

[35]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[36]  R. Tamblyn,et al.  The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. , 1995, Journal of clinical epidemiology.

[37]  J. Shaw,et al.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. , 2011, Diabetes research and clinical practice.

[38]  Anuja Roy,et al.  Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[39]  I. Wilson,et al.  Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence , 2007, AIDS and Behavior.

[40]  Gavin Andrews,et al.  Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias , 2004, European Journal of Epidemiology.